Literature DB >> 25168205

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

F A Klok1, T van der Hulle2, P L den Exter2, M Lankeit3, M V Huisman2, S Konstantinides3.   

Abstract

Long-term follow-up studies have consistently demonstrated that after an episode of acute pulmonary embolism (PE), half of patients report functional limitations and/or decreased quality of life up to many years after the acute event. Incomplete thrombus resolution occurs in one-fourth to one-third of patients. Further, pulmonary artery pressure and right ventricular function remain abnormal despite adequate anticoagulant treatment in 10-30% of patients, and 0.5-4% is diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH) which represents the most severe long term complication of acute PE. From these numbers, it seems that CTEPH itself is the extreme manifestation of a much more common phenomenon of permanent changes in pulmonary artery flow, pulmonary gas exchange and/or cardiac function caused by the acute PE and associated with dyspnea and decreased exercise capacity, which in analogy to post-thrombotic syndrome after deep vein thrombosis could be referred to as the post-pulmonary embolism syndrome. The acknowledgement of this syndrome would both be relevant for daily clinical practice and also provide a concept that aids in further understanding of the pathophysiology of CTEPH. In this clinically oriented review, we discuss the established associations and hypotheses between the process of thrombus resolution or persistence, lasting hemodynamic changes following acute PE as well as the consequences of a PE diagnosis on long-term physical performance and quality of life.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Chronic thromboembolic pulmonary hypertension; Exercise tolerance; Pulmonary artery pressure; Pulmonary embolism; Quality of life; Right ventricular function

Mesh:

Substances:

Year:  2014        PMID: 25168205     DOI: 10.1016/j.blre.2014.07.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  65 in total

1.  Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus.

Authors:  Sangjun Yoo; Sang Hoon Song; Heounjeong Go; Dalsan You; Cheryn Song; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  Int Urol Nephrol       Date:  2017-04-11       Impact factor: 2.370

2.  The link between chronic thromboembolic pulmonary hypertension and sarcoidosis: association or visual masquerade?

Authors:  Rajive Tandon; Robert P Baughman; Janice Stanley; Ali A Khan
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Reduction in physical function in women after venous thromboembolism.

Authors:  K A Hagan; L B Harrington; J Kim; O Zeleznik; E B Rimm; F Grodstein; C Kabrhel
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

4.  Midterm outcomes of catheter-directed interventions for the treatment of acute pulmonary embolism.

Authors:  Nathan L Liang; Rabih A Chaer; Luke K Marone; Michael J Singh; Michel S Makaroun; Efthymios D Avgerinos
Journal:  Vascular       Date:  2016-07-09       Impact factor: 1.285

5.  Risk of venous thromboembolism after endoprosthetic surgeries: lower versus upper extremity endoprosthetic surgeries.

Authors:  Karsten Keller; Lukas Hobohm; Martin Engelhardt
Journal:  Heart Vessels       Date:  2018-11-15       Impact factor: 2.037

6.  Post pulmonary embolism syndrome: a common, underdiagnosed complication that is not well recognised.

Authors:  Alexander Sanders; Max Matonhodze
Journal:  BMJ Case Rep       Date:  2019-02-22

Review 7.  Rationale for catheter directed therapy in pulmonary embolism.

Authors:  Sailen G Naidu; Martha-Gracia Knuttinen; J Scott Kriegshauser; William G Eversman; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries.

Authors:  Tim Nestler; Johannes Huber; Adrienne M Laury; Hendrik Isbarn; Axel Heidenreich; Hans U Schmelz; Christian G Ruf
Journal:  World J Urol       Date:  2018-02-07       Impact factor: 4.226

9.  Endothelial dysfunction and thromboembolism in children, adolescents, and young adults with acute lymphoblastic leukemia.

Authors:  Liv Andrés-Jensen; Kathrine Grell; Cecilie Utke Rank; Birgitte Klug Albertsen; Ruta Tuckuviene; Rikke Linnemann Nielsen; Line Stensig Lynggaard; Kirsten Brunsvig Jarvis; Petter Quist-Paulsen; Sonata Saulyte Trakymiene; Rūta Semaškevičienė; Kadri Saks; Olafur Gisli Jonsson; Thomas Leth Frandsen; Pär Ingemar Johansson; Kjeld Schmiegelow
Journal:  Leukemia       Date:  2021-08-13       Impact factor: 11.528

10.  Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis.

Authors:  Lisette F van Dam; Wilbert B van den Hout; Gargi Gautam; Charlotte E A Dronkers; Waleed Ghanima; Jostein Gleditsch; Anders von Heijne; Herman M A Hofstee; Marcel M C Hovens; Menno V Huisman; Stan Kolman; Albert T A Mairuhu; Mathilde Nijkeuter; Marcel A van de Ree; Cornelis J van Rooden; Robin E Westerbeek; Jan Westerink; Eli Westerlund; Lucia J M Kroft; Frederikus A Klok
Journal:  Blood Adv       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.